drug

SGT-003

Phase 2updated 3mo ago

by $SLDB Solid Biosciences Inc.

Phase 2

community read0 votes

indications

Duchenne Muscular Dystrophy

all catalysts(0)

nothing on the calendar yet

Trials studying SGT-003

phase3A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)recruitingn=80
phase2A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)recruitingn=60

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 12m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

SGT-003

Phase 2updated 3mo ago

by $SLDB Solid Biosciences Inc.

Phase 2

community read0 votes

indications

Duchenne Muscular Dystrophy

all catalysts(0)

nothing on the calendar yet

Trials studying SGT-003

phase3A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)recruitingn=80
phase2A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)recruitingn=60

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 12m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

SGT-003

indications

all catalysts(0)

Trials studying SGT-003

News(0)

Report a data issue

comments(0)

SGT-003

indications

all catalysts(0)

Trials studying SGT-003

News(0)

Report a data issue

comments(0)